Abstract
Cilia are present in most vertebrate tissues with a wide variety of functions, and abnormalities of cilia are linked to numerous human disorders. However, the molecular events underlying ciliary homeostasis are poorly understood. In this study, we generated double knockout (DKO) mice for the deubiquitinase cylindromatosis (CYLD) and histone deacetylase 6 (HDAC6), two critical ciliary regulators. The Cyld/Hdac6 DKO mice were phenotypically normal and showed no obvious variances in weight or behavior compared with their wild-type littermates. Strikingly, Cyld loss-induced ciliary defects in the testis, trachea, and kidney were abrogated in the Cyld/Hdac6 DKO mice. In addition, the diminished α-tubulin acetylation and impaired sonic hedgehog signaling caused by loss of Cyld were largely restored by simultaneous deletion of Hdac6. We further found by immunofluorescence microscopy a colocalization of CYLD and HDAC6 at the centrosome/basal body and, interestingly, loss of Cyld promoted the localization of HDAC6 at the centrosome/basal body. These findings provide physiological insight into the ciliary role of the CYLD/HDAC6 axis and suggest a functional interplay between these two proteins in ciliary homeostasis.
Keywords: cylindromatosis, histone deacetylase 6, knockout mouse, cilium, centrosome
INTRODUCTION
Cilia extend from the surfaces of most mammalian cell types, functioning as sensory and motile organelles. A variety of developmental disorders and pathological conditions have been shown to arise from ciliary defects and are termed ciliopathies [1]. Mutations in cilium-associated structural or signaling proteins cause insensitivity to environmental signals, resulting in disorganized and hyperplastic cell growth in disorders such as polycystic kidney disease (PKD) and Bardet-Biedl syndrome (BBS). At the organismal level, ciliary defects induce infertility, respiratory diseases, renal cysts, situs inversus, and hypertension. Over the past decade, our understanding of the composition and structure of cilia have been greatly improved [2]. However, little is known regarding the mechanisms that regulate ciliary homeostasis.
Cylindromatosis (CYLD), a microtubule-associated deubiquitinase involved in the regulation of diverse biological processes such as cell signaling [3], cell migration [4–6], cell cycle progression [7–11], and cancer [12], has recently been identified as a crucial player in ciliogenesis [13, 14]. Cyld knockout (CKO) mice exhibit ciliary defects across multiple organs, varying from structural and functional deficiencies to cilium-related disorders [13]. Interestingly, inhibition of histone deacetylase 6 (HDAC6), a cytoplasmic enzyme critically involved in the regulation of cilia [15–27], with small-molecule inhibitors partially restores the ciliary defects in CKO mice [13]. To explore the physiological mechanisms underlying the ciliary role of the CYLD/HDAC6 axis, we generated Cyld/Hdac6 double knockout (DKO) mice. Phenotypic characterization of these mice demonstrates a functional interplay between CYLD and HDAC6 in ciliary homeostasis.
RESULTS
Generation and confirmation of Cyld/Hdac6 DKO mice
Because male CKO mice are infertile [28], and Hdac6 is an X-linked gene [29], we selected female CKO mice (i.e., Cyld −/−, Hdac6 +/+) and male Hdac6 KO (HKO) mice (i.e., Cyld +/+, Hdac6 −/Y) for the production of first-generation heterozygous mice (Figure 1A). Male Cyld/Hdac6 DKO mice were then generated at a Mendelian frequency of 1:16 in the second generation by breeding female Cyld/Hdac6 double heterozygous (DHZ) mice (i.e., Cyld +/−, Hdac6 +/−) with male Cyld heterozygous (CHZ) mice (i.e., Cyld +/−, Hdac6 +/Y) (Figure 1A). The male Cyld/Hdac6 DKO mice were viable and phenotypically normal, and showed no obvious variances in weight or behavior compared with their wild-type (WT) littermates. Male second-generation mice, including WT (i.e., Cyld +/+, Hdac6 +/Y), CKO (i.e., Cyld −/−, Hdac6 +/Y), HKO (i.e., Cyld +/+, Hdac6 −/Y), and DKO mice, were selected for subsequent experiments due to the nature of the study, which included examination of sperm flagella.
To confirm the status of Cyld and Hdac6 genes, we performed genotyping analysis for the first-generation (Figure 1B) and second-generation mice (Figure 1C). PCR analysis of mouse tail DNA with Cyld-specific primers produced a 200-bp band for WT and HKO mice, a 250-bp band for CKO and DKO mice, and both bands for DHZ and CHZ mice (Figure 1B and 1C). Similarly, PCR analysis with Hdac6-specific primers produced a 300-bp band for WT and CKO mice, a 250-bp band for HKO, DKO, and CHZ mice, and both bands for DHZ mice (Figure 1B and 1C). Western blot analysis of mouse liver lysates with antibodies specific for CYLD and HDAC6 confirmed that CYLD was not expressed in CKO mice, HDAC6 not expressed in HKO mice, and neither protein expressed in DKO mice (Figure 1D).
Sperm flagellar defects induced by loss of Cyld are partially rescued by deletion of Hdac6
We examined sperm isolated from the epididymides of WT, CKO, HKO, and DKO mice. Consistent with our previous results [13], CKO mice produced impaired sperm, for which both the density of sperm and the length of sperm flagella were reduced (Figure 2A and 2B). In agreement with the previously reported effects of HDAC6 inhibitors and HDAC6 siRNAs on ciliogenesis [25], deletion of Hdac6 did not significantly affect the density of sperm or the length of sperm flagella (Figure 2A and 2B). However, the sperm density and flagellar defects induced by loss of Cyld were partially restored in DKO mice (Figure 2A and 2B). We next analyzed sperm flagella in the testis by immunofluorescence staining with an antibody directed against acetylated α-tubulin, a well-characterized ciliary marker. Similar to results for isolated sperm, we found that the flagellar length was also partially rescued in DKO mice (Figure 2C and 2D). Together, these results suggest that the flagellar defects induced by loss of Cyld are partially rescued by deletion of Hdac6.
Cyld/Hdac6 DKO mice are protected from ciliary defects in the tracheal epithelium
To investigate whether ciliary defects in the trachea caused by loss of Cyld could be rescued in Cyld/Hdac6 DKO mice, scanning electron microscopy was performed to examine the tracheal surface epithelium of WT, CKO, HKO, and DKO mice. We found that CKO mice exhibited reductions in the percentage of ciliated cells and ciliary length, while HKO mice showed no significant ciliary defects compared with WT mice (Figures 3A–3C). In DKO mice, the percentage of ciliated cells and the length of cilia were significantly increased compared with CKO mice (Figures 3A–3C). Similar results were obtained by immunofluorescence staining of cilia in mouse trachea (Figures 3D–3F). These results indicate that tracheal motile ciliary defects induced by loss of Cyld are significantly rescued in DKO mice.
Cyld/Hdac6 DKO abrogates Cyld loss-induced ciliary defects in the kidney
We then examined whether renal ciliary defects caused by loss of Cyld are rescued by deletion of Hdac6. The primary cilia in the collecting ducts of the kidney were stained with acetylated α-tubulin antibody. We found that CKO mice exhibited reduced percentage of ciliated cells and decreased ciliary length, while deletion of Hdac6 did not significantly affect cilia compared with WT mice (Figures 4A–4C). However, in DKO mice, ciliary defects induced by loss of Cyld in the kidney were efficiently rescued (Figures 4A–4C). These data suggest that DKO dramatically ablated the effect of Cyld loss on cilia.
Since PKD has been strongly associated with ciliary defects in the kidney [30], we sought to investigate whether the CYLD/HDAC6 axis contributes to this disease. We first examined the kidney weight/body weight ratio (KW/BW) of WT, CKO, HKO, and DKO mice and found no significant difference among these mice (Figure 4D). We then performed hematoxylin and eosin (H & E) staining of kidneys from WT, CKO, HKO, and DKO mice. We found that, similar to WT mice, CKO, HKO, and DKO mice did not exhibit obvious cysts in the kidney (Figure 4E). These data suggest that ciliary defects in the kidney do not always precipitate PKD.
Cyld loss-induced ciliary defects in mouse embryonic fibroblasts (MEFs) are significantly rescued by deletion of Hdac6
The next question then is whether Cyld loss-induced ciliary defects could be rescued by deletion of Hdac6 in vitro. To answer this question, we investigated WT, CKO, HKO, and DKO MEFs. To induce ciliary formation, MEFs were cultured in serum-free medium for 48 hours. We found that both the percentage of ciliated cells and the length of cilia were dramatically reduced in CKO MEFs and that deletion of Hdac6 did not affect cilia compared to WT MEFs (Figures 5A–5C). However, the ciliary defects induced by loss of Cyld were significantly restored in DKO MEFs (Figures 5A–5C).
To explore the molecular mechanism pertaining to the function of HDAC6 in the ciliary action of CYLD, MEFs were cultured in serum-free medium for 48 hours and double stained with CYLD and HDAC6 antibodies. We found that in a population of MEFs where HDAC6 were enriched at the centrosome/basal body, CYLD was also enriched in this region (Figure 5D). We next compared the localization of HDAC6 in WT and CKO MEFs. We found that loss of Cyld dramatically increased the intensity of HDAC6 localized at the centrosome/basal body (Figure 5E and 5F). In addition, simultaneous deletion of Hdac6 significantly reversed the reduction of α-tubulin acetylation observed in CKO MEFs (Figure 5G). Together with previous findings [13], these results indicate that deletion of Hdac6 in CKO mice significantly reverses Cyld loss-induced ciliary defects by acting on the localization and activity of HDAC6.
Sonic hedgehog (Shh) signaling is restored in Cyld/Hdac6 DKO MEFs
Because the CYLD/HDAC6 axis is involved in ciliary homeostasis [13], and ciliary assembly is required for the Shh signaling [31], we next assessed the Shh pathway in WT, CKO, HKO, and DKO MEFs. MEFs were cultured in serum-free medium for 24 hours, followed by treatment with conditioned serum-free medium containing the amino-terminal domain of Shh (ShhN) for 24 hours. Cells were then stained with antibodies directed against Gli1 and Gli2, two key transcriptional regulators of the Shh signaling [31]. We found that loss of Cyld dramatically reduced the proportion of Gli1 and Gli2 in the nucleus, but deletion of Hdac6 did not significantly affect nuclear localization of these two proteins (Figures 6A–6C). In contrast, in DKO MEFs, the impaired nuclear localization of Gli1 and Gli2 was significantly restored (Figures 6A–6C). We also analyzed the mRNA levels of Gli1 and Gli2. In CKO MEFs, the mRNA levels of these two proteins were reduced, and in HKO MEFs, their mRNA levels were up-regulated compared to WT MEFs (Figure 6D and 6E). In DKO MEFs, the reduced mRNA levels induced by loss of Cyld were substantially reversed (Figure 6D and 6E). These data indicate that the impaired Shh signaling in CKO MEFs is efficiently restored by simultaneous deletion of Hdac6.
DISCUSSION
HDAC6 is a cytoplasmic member of the HDAC family. Unlike most other HDACs, HDAC6 primarily deacetylates non-histone proteins and thereby plays important roles in a variety of cellular processes, such as cell signaling, cell motility, and cell-cell interactions [32–43]. Recently, there is accumulating evidence that HDAC6 is a critical regulator of ciliary homeostasis [15–26]. α-Tubulin and cortactin, two substrates of the deacetylase activity of HDAC6, have been identified as the major downstream elements that mediate the ciliary function of HDAC6 [25]. In addition, HDAC6 has been shown to mediate the actions of other cilium-associated proteins, such as Aurora A, death inducer obliterator 3 (Dido3), and Polo-like kinase 1 (Plk1) [15–26]. While the molecular mechanisms by which these proteins regulate the ciliary role of HDAC6 are elusive, our data demonstrate that HDAC6 is enriched at the centrosome/basal body and that this localization is enhanced by the loss of Cyld. These findings suggest that regulation of HDAC6 localization or activity at the centrosome/basal body may represent a critical mechanism controlling the functions of HDAC6 in ciliary homeostasis.
CYLD was initially identified as a tumor suppressor and has recently been identified as an important ciliary regulator, as both CKO mice and transgenic mice carrying truncations in the carboxyl-terminal deubiquitinase domain of CYLD exhibit ciliary defects [13, 14]. Our data show that ciliary defects resulting from loss of Cyld are efficiently reversed by simultaneous deletion of Hdac6 in organs ranging from the trachea to the kidney, as well as at the cellular level in MEFs. CKO mice have impaired flagella, and since a properly functioning flagellum is essential for sperm motility, these mice are infertile. Interestingly, although the sperm flagellar defects induced by loss of Cyld are partially restored in Cyld/Hdac6 DKO mice, these mice remain infertile. However, this is not surprising given that spermatogenesis is a tightly controlled event, and the formation of flagella is only one element of this process. Further studies are warranted to examine the functionality of the flagella in DKO mice, such as sperm motility.
Over the past decade, HDAC6 has emerged as an attractive target for the treatment of a variety of diseases, including neurodegenerative disorders and cancer [44–46]. Unlike many pan-HDAC inhibitors, HDAC6-targeted therapies exhibit no obvious side effects. For example, tubastain A, a selective inhibitor of HDAC6, have been shown to protect mice from diverse ciliary defects without causing toxicity to normal tissues [13]. Tubastain A also restores cilia in cholangiocarcinoma cells and induces a significant decrease in tumor growth in a cholangiocarcinoma animal model without causing obvious side effects [46]. The present study demonstrates that deletion of Hdac6 rescues ciliary defects induced by Cyld loss in the testis, trachea, and kidney without affecting other organs. These data, together with previous findings that small-molecule compounds inhibiting HDAC6 restore ciliary defects in nephronophthisis and chronic obstructive pulmonary disease [18, 26], suggest the potential therapeutic value of HDAC6-selective inhibitors in ciliopathies.
MATERIALS AND METHODS
Ethics statement
Investigation has been conducted in accordance with the ethical standards according to the Declaration of Helsinki and the national and international guidelines, and has been approved by the authors' institutional review board.
Mice
CKO and HKO mice were generated and genotyped as described previously [47, 48]. Cyld/Hdac6 DKO mice were generated and genotyped as described in Figure 1. Six mice were used for each experimental group.
Cell culture
MEFs were isolated from E13.5 mouse embryos as described previously [13]. All MEFs were cultured in Dulbecco's Modified Essential Medium supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2. To induce ciliary formation, MEFs were cultured in serum-free medium for 48 hours.
Antibodies
Antibodies against acetylated α-tubulin, γ-tubulin, β-actin (Sigma-Aldrich), CYLD, Gli1 (Santa Cruz Biotechnology), α-tubulin and Gli2 (Abcam), and HDAC6 (Abgent) were purchased from the indicated sources. Fluorescein- and rhodamine-conjugated secondary antibodies were purchased from Jackson ImmunoResearch Laboratories, and horseradish peroxidase-conjugated secondary antibodies were purchased from Santa Cruz Biotechnology.
Immunofluorescence microscopy
Mouse tissues were fixed in 4% paraformaldehyde, embedded, and snap-frozen in liquid nitrogen prior to sectioning as described [9]. Tissue sections or MEFs grown on glass coverslips were fixed with 4% paraformaldehyde for 20 minutes and permeabilized in 0.5% Triton X-100 in PBS for 20 minutes at room temperature. They were then blocked with a buffer containing 2% bovine serum albumin in PBS for 1 hour at room temperature. Sections were then incubated with indicated primary antibodies overnight at 4°C and with appropriate secondary antibodies for 1 hour at room temperature, followed by staining with DAPI (Sigma-Aldrich). Finally, the coverslips were mounted with anti-fade medium and examined with a TCS SP5 confocal microscope (Leica). The percentage of ciliated cells and ciliary length were measured using the ImageJ software (National Institutes of Health, USA). The fluorescence intensity of proteins at specific regions was quantified as described previously [49].
Scanning electron microscopy
Mouse tracheal samples were isolated and fixed with 2.5% (vol/vol) glutaraldehyde in 0.1 M sodium cacodylate as described previously [13]. Samples were post-fixed in 1% (wt/vol) osmium tetroxide for 2 hours, dehydrated with graded ethanol, and dried in a critical point dryer. The samples were gold-coated and examined with a QUANTA 200 scanning electron microscope.
Sperm analysis
Sperm were extracted from cauda epididymides, and the length of flagella were measured with the ImageJ software as described previously [13].
Histological analysis
Kidneys were harvested immediately after mice were sacrificed, and kidney/body weights were recorded. Samples were fixed in 10% formalin overnight at 4°C and embedded in paraffin. Tissue sections (4 μm) were cut, deparaffinized, rehydrated with graded ethanol, and stained with hematoxylin and eosin (Sigma-Aldrich). Slides were visualized with a Leica DM3000 camera (Leica).
Western blotting
Proteins were resolved by SDS-PAGE and transferred to polyvinylidene difluoride membranes (Millipore). The membranes were blocked with 5% non-fat milk in Tris-buffered saline containing 0.2% Tween 20, then incubated with primary antibodies overnight at 4°C, followed by incubation with appropriate secondary antibodies for 45 minutes at room temperature. Specific proteins were visualized with enhanced chemiluminescence detection reagents according to the manufacturer's instructions (Thermo Fisher Scientific).
Quantitative real-time RT-PCR
Total RNA was isolated from MEFs using the TRIzol reagent (Invitrogen). Quantitative real-time RT-PCR was performed using the SYBR Premix Ex Taq (Perfect Real Time) reagent (Takara) as described previously [50, 51]. β-Actin was used as a control to normalize the reading in each sample.
Statistics
Analysis of statistical significance was performed by the Student's t-test for comparison between two groups and by the ANOVA test for multiple comparisons.
Acknowledgments
We thank Shao-Cong Sun for providing Cyld heterozygous mice and Tso-Pang Yao for Hdac6 heterozygous mice.
Footnotes
CONFLICTS OF INTEREST
The authors have declared that no competing financial interests exist.
GRANT SUPPORT
This work was supported by grants from the National Basic Research Program of China (2012CB945002) and the National Natural Science Foundation of China (31271437 and 31371382).
REFERENCES
- 1.Oh EC, Katsanis N. Cilia in vertebrate development and disease. Development. 2012;139:443–448. doi: 10.1242/dev.050054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Yuan S, Sun Z. Expanding horizons: ciliary proteins reach beyond cilia. Annu Rev Genet. 2013;47:353–376. doi: 10.1146/annurev-genet-111212-133243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Massoumi R. Ubiquitin chain cleavage: CYLD at work. Trends Biochem Sci. 2010;35:392–399. doi: 10.1016/j.tibs.2010.02.007. [DOI] [PubMed] [Google Scholar]
- 4.Gao J, Huo L, Sun X, Liu M, Li D, Dong JT, Zhou J. The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration. J Biol Chem. 2008;283:8802–8809. doi: 10.1074/jbc.M708470200. [DOI] [PubMed] [Google Scholar]
- 5.Gao J, Sun L, Huo L, Liu M, Li D, Zhou J. CYLD regulates angiogenesis by mediating vascular endothelial cell migration. Blood. 2010;115:4130–4137. doi: 10.1182/blood-2009-10-248526. [DOI] [PubMed] [Google Scholar]
- 6.Li D, Gao J, Yang Y, Sun L, Suo S, Luo Y, Shui W, Zhou J, Liu M. CYLD coordinates with EB1 to regulate microtubule dynamics and cell migration. Cell Cycle. 2014;13:974–983. doi: 10.4161/cc.27838. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Stegmeier F, Sowa ME, Nalepa G, Gygi SP, Harper JW, Elledge SJ. The tumor suppressor CYLD regulates entry into mitosis. Proc Natl Acad Sci U S A. 2007;104:8869–8874. doi: 10.1073/pnas.0703268104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sun L, Gao J, Huo L, Sun X, Shi X, Liu M, Li D, Zhang C, Zhou J. Tumour suppressor CYLD is a negative regulator of the mitotic kinase Aurora-B. J Pathol. 2010;221:425–432. doi: 10.1002/path.2723. [DOI] [PubMed] [Google Scholar]
- 9.Yang Y, Liu M, Li D, Ran J, Gao J, Suo S, Sun SC, Zhou J. CYLD regulates spindle orientation by stabilizing astral microtubules and promoting dishevelled-NuMA-dynein/dynactin complex formation. Proc Natl Acad Sci U S A. 2014;111:2158–2163. doi: 10.1073/pnas.1319341111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wickstrom SA, Masoumi KC, Khochbin S, Fassler R, Massoumi R. CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin. EMBO J. 2010;29:131–144. doi: 10.1038/emboj.2009.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Yang Y, Ran J, Sun L, Sun X, Luo Y, Yan B, Tala, Liu M, Li D, Zhang L, Bao G, Zhou J. CYLD regulates noscapine activity in acute lymphoblastic leukemia via a microtubule-dependent mechanism. Theranostics. 2015;5:656–666. doi: 10.7150/thno.10844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Massoumi R. CYLD: a deubiquitination enzyme with multiple roles in cancer. Future Oncol. 2011;7:285–297. doi: 10.2217/fon.10.187. [DOI] [PubMed] [Google Scholar]
- 13.Yang Y, Ran J, Liu M, Li D, Li Y, Shi X, Meng D, Pan J, Ou G, Aneja R, Sun SC, Zhou J. CYLD mediates ciliogenesis in multiple organs by deubiquitinating Cep70 and inactivating HDAC6. Cell Res. 2014;24:1342–1353. doi: 10.1038/cr.2014.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Eguether T, Ermolaeva MA, Zhao Y, Bonnet MC, Jain A, Pasparakis M, Courtois G, Tassin AM. The deubiquitinating enzyme CYLD controls apical docking of basal bodies in ciliated epithelial cells. Nat Commun. 2014;5:4585. doi: 10.1038/ncomms5585. [DOI] [PubMed] [Google Scholar]
- 15.Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent Aurora A activation induces disassembly of the primary cilium. Cell. 2007;129:1351–1363. doi: 10.1016/j.cell.2007.04.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kinzel D, Boldt K, Davis EE, Burtscher I, Trumbach D, Diplas B, Attie-Bitach T, Wurst W, Katsanis N, Ueffing M, Lickert H. Pitchfork regulates primary cilia disassembly and left-right asymmetry. Dev Cell. 2010;19:66–77. doi: 10.1016/j.devcel.2010.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Plotnikova OV, Nikonova AS, Loskutov YV, Kozyulina PY, Pugacheva EN, Golemis EA. Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis. Mol Biol Cell. 2012;23:2658–2670. doi: 10.1091/mbc.E11-12-1056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Mergen M, Engel C, Muller B, Follo M, Schafer T, Jung M, Walz G. The nephronophthisis gene product NPHP2/Inversin interacts with Aurora A and interferes with HDAC6-mediated cilia disassembly. Nephrol Dial Transplant. 2013;28:2744–2753. doi: 10.1093/ndt/gft316. [DOI] [PubMed] [Google Scholar]
- 19.Kim M, Kim M, Lee MS, Kim CH, Lim DS. The MST1/2-SAV1 complex of the Hippo pathway promotes ciliogenesis. Nat Commun. 2014;5:5370. doi: 10.1038/ncomms6370. [DOI] [PubMed] [Google Scholar]
- 20.Dere R, Perkins AL, Bawa-Khalfe T, Jonasch D, Walker CL. beta-catenin links von hippel-lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma. J Am Soc Nephrol. 2015;26:553–564. doi: 10.1681/ASN.2013090984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Li Y, Wei Q, Zhang Y, Ling K, Hu J. The small GTPases ARL-13 and ARL-3 coordinate intraflagellar transport and ciliogenesis. J Cell Biol. 2010;189:1039–1051. doi: 10.1083/jcb.200912001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Sanchez de Diego A, Alonso Guerrero A, Martinez AC, van Wely KH. Dido3-dependent HDAC6 targeting controls cilium size. Nat Commun. 2014;5:3500. doi: 10.1038/ncomms4500. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Wang G, Chen Q, Zhang X, Zhang B, Zhuo X, Liu J, Jiang Q, Zhang C. PCM1 recruits Plk1 to the pericentriolar matrix to promote primary cilia disassembly before mitotic entry. J Cell Sci. 2013;126:1355–1365. doi: 10.1242/jcs.114918. [DOI] [PubMed] [Google Scholar]
- 24.Loktev AV, Zhang Q, Beck JS, Searby CC, Scheetz TE, Bazan JF, Slusarski DC, Sheffield VC, Jackson PK, Nachury MV. A BBSome subunit links ciliogenesis, microtubule stability, and acetylation. Dev Cell. 2008;15:854–865. doi: 10.1016/j.devcel.2008.11.001. [DOI] [PubMed] [Google Scholar]
- 25.Ran J, Yang Y, Li D, Liu M, Zhou J. Deacetylation of alpha-tubulin and cortactin is required for HDAC6 to trigger ciliary disassembly. Sci Rep. 2015;5:12917. doi: 10.1038/srep12917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Lam HC, Cloonan SM, Bhashyam AR, Haspel JA, Singh A, Sathirapongsasuti JF, Cervo M, Yao H, Chung AL, Mizumura K, An CH, Shan B, Franks JM, et al. Histone deacetylase 6-mediated selective autophagy regulates COPD-associated cilia dysfunction. J Clin Invest. 2013;123:5212–5230. doi: 10.1172/JCI69636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Yu F, Ran J, Zhou J. Ciliopathies: does HDAC6 represent a new therapeutic target? Trends Pharmacol Sci. 2016;37:114–119. doi: 10.1016/j.tips.2015.11.002. [DOI] [PubMed] [Google Scholar]
- 28.Wright A, Reiley WW, Chang M, Jin W, Lee AJ, Zhang M, Sun SC. Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD. Dev Cell. 2007;13:705–716. doi: 10.1016/j.devcel.2007.09.007. [DOI] [PubMed] [Google Scholar]
- 29.Mahlknecht U, Schnittger S, Landgraf F, Schoch C, Ottmann OG, Hiddemann W, Hoelzer D. Assignment of the human histone deacetylase 6 gene (HDAC6) to X chromosome p11. 23 by in situ hybridization. Cytogenet Cell Genet. 2001;93:135–136. doi: 10.1159/000056967. [DOI] [PubMed] [Google Scholar]
- 30.Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321–337. doi: 10.1146/annurev.med.60.101707.125712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Briscoe J, Therond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 2013;14:416–429. doi: 10.1038/nrm3598. [DOI] [PubMed] [Google Scholar]
- 32.Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP. HDAC6 is a microtubule-associated deacetylase. Nature. 2002;417:455–458. doi: 10.1038/417455a. [DOI] [PubMed] [Google Scholar]
- 33.Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D, Osada H, Komatsu Y, Nishino N, Khochbin S, Horinouchi S, Yoshida M. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 2002;21:6820–6831. doi: 10.1093/emboj/cdf682. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, Olashaw N, Parsons JT, Yang XJ, Dent SR, Yao TP, Lane WS, Seto E. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell. 2007;27:197–213. doi: 10.1016/j.molcel.2007.05.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Zhang Y, Li N, Caron C, Matthias G, Hess D, Khochbin S, Matthias P. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 2003;22:1168–1179. doi: 10.1093/emboj/cdg115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, Nicchitta CV, Yoshida M, Toft DO, Pratt WB, Yao TP. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell. 2005;18:601–607. doi: 10.1016/j.molcel.2005.04.021. [DOI] [PubMed] [Google Scholar]
- 37.Huo L, Li D, Sun X, Shi X, Karna P, Yang W, Liu M, Qiao W, Aneja R, Zhou J. Regulation of Tat acetylation and transactivation activity by the microtubule-associated deacetylase HDAC6. J Biol Chem. 2011;286:9280–9286. doi: 10.1074/jbc.M110.208884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Parmigiani RB, Xu WS, Venta-Perez G, Erdjument-Bromage H, Yaneva M, Tempst P, Marks PA. HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. Proc Natl Acad Sci U S A. 2008;105:9633–9638. doi: 10.1073/pnas.0803749105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Zhang L, Liu S, Liu N, Zhang Y, Liu M, Li D, Seto E, Yao TP, Shui W, Zhou J. Proteomic identification and functional characterization of MYH9, Hsc70, and DNAJA1 as novel substrates of HDAC6 deacetylase activity. Protein Cell. 2015;6:42–54. doi: 10.1007/s13238-014-0102-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kaluza D, Kroll J, Gesierich S, Yao TP, Boon RA, Hergenreider E, Tjwa M, Rossig L, Seto E, Augustin HG, Zeiher AM, Dimmeler S, Urbich C. Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin. EMBO J. 2011;30:4142–4156. doi: 10.1038/emboj.2011.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Li D, Xie S, Ren Y, Huo L, Gao J, Cui D, Liu M, Zhou J. Microtubule-associated deacetylase HDAC6 promotes angiogenesis by regulating cell migration in an EB1-dependent manner. Protein Cell. 2011;2:150–160. doi: 10.1007/s13238-011-1015-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Liu N, Xiong Y, Li S, Ren Y, He Q, Gao S, Zhou J, Shui W. New HDAC6-mediated deacetylation sites of tubulin in the mouse brain identified by quantitative mass spectrometry. Sci Rep. 2015;5:16869. doi: 10.1038/srep16869. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Li D, Sun X, Zhang L, Yan B, Xie S, Liu R, Liu M, Zhou J. Histone deacetylase 6 and cytoplasmic linker protein 170 function together to regulate the motility of pancreatic cancer cells. Protein Cell. 2014;5:214–223. doi: 10.1007/s13238-013-0010-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.d'Ydewalle C, Krishnan J, Chiheb DM, Van Damme P, Irobi J, Kozikowski AP, Vanden Berghe P, Timmerman V, Robberecht W, Van Den Bosch L. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med. 2011;17:968–974. doi: 10.1038/nm.2396. [DOI] [PubMed] [Google Scholar]
- 45.Rivieccio MA, Brochier C, Willis DE, Walker BA, D'Annibale MA, McLaughlin K, Siddiq A, Kozikowski AP, Jaffrey SR, Twiss JL, Ratan RR, Langley B. HDAC6 is a target for protection and regeneration following injury in the nervous system. Proc Natl Acad Sci U S A. 2009;106:19599–19604. doi: 10.1073/pnas.0907935106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Gradilone SA, Radtke BN, Bogert PS, Huang BQ, Gajdos GB, LaRusso NF. HDAC6 inhibition restores ciliary expression and decreases tumor growth. Cancer Res. 2013;73:2259–2270. doi: 10.1158/0008-5472.CAN-12-2938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Reiley WW, Zhang M, Jin W, Losiewicz M, Donohue KB, Norbury CC, Sun SC. Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat Immunol. 2006;7:411–417. doi: 10.1038/ni1315. [DOI] [PubMed] [Google Scholar]
- 48.Gao YS, Hubbert CC, Lu J, Lee YS, Lee JY, Yao TP. Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis. Mol Cell Biol. 2007;27:8637–8647. doi: 10.1128/MCB.00393-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Shi X, Sun X, Liu M, Li D, Aneja R, Zhou J. CEP70 protein interacts with gamma-tubulin to localize at the centrosome and is critical for mitotic spindle assembly. J Biol Chem. 2011;286:33401–33408. doi: 10.1074/jbc.M111.252262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Liu M, Wang X, Yang Y, Li D, Ren H, Zhu Q, Chen Q, Han S, Hao J, Zhou J. Ectopic expression of the microtubule-dependent motor protein Eg5 promotes pancreatic tumourigenesis. J Pathol. 2010;221:221–228. doi: 10.1002/path.2706. [DOI] [PubMed] [Google Scholar]
- 51.Xie S, Qin J, Liu S, Zhang Y, Wang J, Shi X, Li D, Zhou J, Liu M. Cep70 overexpression stimulates pancreatic cancer by inducing centrosome abnormality and microtubule disorganization. Sci Rep. 2016;6:21263. doi: 10.1038/srep21263. [DOI] [PMC free article] [PubMed] [Google Scholar]